Lahore: Highnoon Laboratories Limited has scheduled a meeting of its Board of Directors to be held on Thursday, August 27, 2026, at 11:00 a.m. The meeting will take place at the company’s corporate office in Lahore, where the board will review and approve the interim accounts for the half-year period ending on June 30, 2026, among other agenda items.
The company has declared a “Closed Period” from August 20, 2026, to August 27, 2026, in compliance with clause 5.6.4 of the Pakistan Stock Exchange (PSX) Regulations. During this period, no director, CEO, or executive is permitted to engage in any transactions involving the company’s shares, either directly or indirectly.
According to information available from the Pakistan Stock Exchange (PSX), this measure is a routine procedure intended to ensure fair trading practices and maintain market integrity. The closed period is a standard regulatory requirement designed to prevent any potential misuse of insider information by the company’s executives and board members.
Highnoon Laboratories Limited, categorized under the designated market category of the pharmaceutical sector, continues to adhere to these regulatory measures to uphold transparency and accountability within its operations. The outcome of the board meeting will be closely monitored by investors and market analysts, as it may provide insights into the company’s financial health and future prospects.